The aim of the Journal is to provide a forum for the critical analysis of advanced drugand gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery. 

In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues. 

Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution. 

Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors. 

Paper

Editor-in-Chief
Hamid Ghandehari, PhD
The University of Utah, Salt Lake City, Utah, United States
Executive Editors
Hak-Kim Chan
The University of Sydney School of Pharmacy, Sydney, Australia
Katja Schenke-Layland, MSc, PhD
Eberhard Karls University Tübingen, Tubingen, Germany
Hideyoshi Harashima
Hokkaido University Faculty of Pharmaceutical Sciences, Sapporo, Japan
Tamara Minko
Rutgers University Department of Pharmaceutics, Piscataway, New Jersey, United States
Andrew MacKay
University of Southern California, Los Angeles, California, United States
Maria Jesus Vicent
CIPF Bioinformatics Department, Valencia, Spain
Editorial Board
Christine Allen, PhD
Toronto, Ontario, Canada
Sangeeta Bhatia
Cambridge, Massachusetts, United States
David Brayden
Dublin, Ireland
Patrick Couvreur
Chatenay Malabry, France
Daan Crommelin
Utrecht, Netherlands
Tejal Desai
San Francisco, California, United States
Avi Domb
Jerusalem, Israel
David Grainger
Salt Lake City, Utah, United States
Mark Gumbleton
Cardiff, United Kingdom
Sarah Hamm-Alvarez
Los Angeles, California, United States
Justin Hanes
Baltimore, Maryland, United States
Mitsuru Hashida
Kyoto, Japan
Wim Hennink
Utrecht, Netherlands
Alexander Kabanov
Chapel Hill, North Carolina, United States
Kazunori Kataoka
Bunkyo-Ku, Tokyo, Japan
Thomas Kissel
Marburg, Germany
Jindrich Henry Kopecek
Salt Lake City, Utah, United States
Ick Chan Kwon
Seongbuk-Gu, Seoul, Korea, Republic of
Robert S. Langer
Cambridge, Massachusetts, United States
Claus-Michael Lehr, PhD
Saarbruecken, Germany
Ram I. Mahato
Omaha, Nebraska, United States
Yasuhiro Matsumura, MD, PhD
Kashiwa, Japan
Tony Mikos, PhD, MSChE
Houston, Texas, United States
Seyed Moein Moghimi, PhD
Durham, United Kingdom
Sylvia Muro
Baltimore, Maryland, United States
Yu-Kyoung Oh
Seoul, Korea, Republic of
Kinam Park
West Lafayette, Indiana, United States
Nicholas Peppas, ScD
Austin, Texas, United States
David Putnam
Ithaca, New York, United States
Milica Radisic
Toronto, Ontario, Canada
Ronit Satchi-Fainaro
Tel Aviv, Israel
Yuichi Sugiyama
Bunkyo-Ku, Japan
Tetsuya Terasaki
Sendai, Japan
Vladimir Torchilin, PhD, DSc
Boston, Massachusetts, United States
Chun Wang
Minneapolis, Minnesota, United States
Chae-Ok Yun
Seoul, Korea, Republic of
Co-Founder and Senior Editor-in-Chief: (1987-2000)
Eric Tomlinson
Editor-in-Chief: (2000-2010)
Vincent H.L. Lee